Canada · Delayed Price · Currency is CAD Conavi Medical Statistics
Total Valuation
Conavi Medical has a market cap or net worth of CAD 25.36 million. The enterprise value is 39.08 million.
| Market Cap | 25.36M |
| Enterprise Value | 39.08M |
Important Dates
The next estimated earnings date is Thursday, August 27, 2026.
| Earnings Date | Aug 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Conavi Medical has 103.49 million shares outstanding. The number of shares has increased by 233.30% in one year.
| Current Share Class | 103.49M |
| Shares Outstanding | 103.49M |
| Shares Change (YoY) | +233.30% |
| Shares Change (QoQ) | +30.15% |
| Owned by Insiders (%) | 0.42% |
| Owned by Institutions (%) | 0.00% |
| Float | 69.44M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 32.59 |
| PB Ratio | -1.81 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 50.23 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.40
| Current Ratio | 1.40 |
| Quick Ratio | 0.72 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.77 |
| Interest Coverage | -20.70 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -114.98% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -280.06% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.07 |
| Inventory Turnover | 0.32 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -31.94% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -31.94% |
| 50-Day Moving Average | 0.34 |
| 200-Day Moving Average | 0.45 |
| Relative Strength Index (RSI) | 36.94 |
| Average Volume (20 Days) | 24,976 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Conavi Medical had revenue of CAD 778,000 and -17.85 million in losses. Loss per share was -0.22.
| Revenue | 778,000 |
| Gross Profit | 744,000 |
| Operating Income | -19.44M |
| Pretax Income | -17.85M |
| Net Income | -17.85M |
| EBITDA | -19.01M |
| EBIT | -19.44M |
| Loss Per Share | -0.22 |
Balance Sheet
The company has 4.49 million in cash and 18.22 million in debt, with a net cash position of -13.72 million or -0.13 per share.
| Cash & Cash Equivalents | 4.49M |
| Total Debt | 18.22M |
| Net Cash | -13.72M |
| Net Cash Per Share | -0.13 |
| Equity (Book Value) | -13.97M |
| Book Value Per Share | -0.14 |
| Working Capital | 2.95M |
Cash Flow
In the last 12 months, operating cash flow was -23.68 million and capital expenditures -52,000, giving a free cash flow of -23.74 million.
| Operating Cash Flow | -23.68M |
| Capital Expenditures | -52,000 |
| Depreciation & Amortization | 424,000 |
| Net Borrowing | -1.71M |
| Free Cash Flow | -23.74M |
| FCF Per Share | -0.23 |
Margins
| Gross Margin | 95.63% |
| Operating Margin | -2,498.20% |
| Pretax Margin | -2,294.22% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Conavi Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -233.30% |
| Shareholder Yield | -233.30% |
| Earnings Yield | -70.40% |
| FCF Yield | -93.61% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 16, 2024. It was a reverse split with a ratio of 0.04.
| Last Split Date | Oct 16, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.04 |
Scores
Conavi Medical has an Altman Z-Score of -20.45 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -20.45 |
| Piotroski F-Score | 3 |